Finance

Lists
Why is RELF up 8.00%?
Dive Deeper
RELF:IDX
Graha Mitra Asia Tbk PT
IDR 27.00
+8.00%
(+2.00) 1D
Nov 9, 3:48:15 PM GMT+7  ·   IDR
All symbols
SymbolPriceChange% Change
Generating top insights for RELF...
Open
IDR 25
High
IDR 27
Low
IDR 24
Mkt. cap
154.65B
Avg. vol.
23.99M
Volume
10.73M
P/E ratio
22.87
52-wk high
IDR 58
52-wk low
IDR 24
EPS
IDR 1
Shares outstanding
5.73B
No. of employees
9
Open
IDR 25
High
IDR 27
Low
IDR 24
Mkt. cap
154.65B
Avg. vol.
23.99M
Volume
10.73M
P/E ratio
22.87
52-wk high
IDR 58
52-wk low
IDR 24
EPS
IDR 1
Shares outstanding
5.73B
No. of employees
9
News stories
From web sources and news partners
About Graha Mitra Asia Tbk PT
CEO-
Employees9
Founded2018
Headquarters-
SectorReal Estate
Industry-
Websiterelifeasia.com
Previous reportsAll values in IDR
Loading Previous Earnings...
Revenue
Net income
All values in IDR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
10.97B
10.97B
6.92B
6.92B
Cost of goods sold
5.46B
5.46B
3.46B
3.46B
Cost of revenue
5.46B
5.46B
3.46B
3.46B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.67B
2.67B
2.39B
2.39B
Operating expense
2.74B
2.74B
2.45B
2.45B
Total operating expenses
8.19B
8.19B
5.91B
5.91B
Operating income
2.77B
2.77B
1.01B
1.01B
Other non operating income
1.81M
1.81M
25.30M
25.30M
EBT including unusual items
2.79B
2.79B
1.04B
1.04B
EBT excluding unusual items
2.79B
2.79B
1.04B
1.04B
Income tax expense
273.46M
273.46M
172.42M
172.42M
Effective tax rate
9.82%
9.82%
16.56%
16.56%
Other operating expenses
67.03M
67.03M
59.73M
59.73M
Net income
2.51B
2.51B
868.88M
868.88M
Net profit margin
22.91%
22.91%
12.56%
12.56%
Earnings per share
-
-
-
-
Interest and investment income
11.25M
11.25M
10.19M
10.19M
Interest expense
-
-
-
-
Net interest expenses
11.25M
11.25M
10.19M
10.19M
Depreciation and amortization charges
-
-
-
-
EBITDA
2.91B
2.91B
1.15B
1.15B
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps